Company Filing History:

8 out of 2,170

The Upjohn Co.

Years Active: 1982-1988

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4725620 - 2H-pyran-2,6-(3H)-dione derivatives with anti-allergic activity (1988-02-16),

2. 4632935 - Omega-(hydroxy-, ether and ester)-alkyl-2-amino-cycloalkyl- and (1986-12-30),

3. 4598088 - 2-pyrrolyl-cycloalkyl-amide analgesics (1986-07-01),

4. 4588591 - Analgesic 2-oxa-spirocyclic compounds (1986-05-13),

5. 4508911 - Amine intermediates for analgesic compounds (1985-04-02),

6. 4463013 - Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as (1984-07-31),

7. 4460600 - Adjacently substituted ketal derivatives of cycloalkane-amide analgesics (1984-07-17),

8. 4438130 - Analgesic 1-oxa-, aza- and thia-spirocyclic compounds (1984-03-20),

9. 4359476 - Adjacently substituted cycloalkane-amide analgesics (1982-11-16),

Title: The Innovative Contributions of Lester J Kaplan

Introduction

Lester J Kaplan is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 9 patents to his name, Kaplan's work has had a meaningful impact on the treatment of various medical conditions.

Latest Patents

Among his latest patents, Kaplan has developed 2H-pyran-2,6-(3H)-dione derivatives that exhibit anti-allergic activity. These achiral compounds are designed to treat allergic conditions effectively. Additionally, he has worked on omega-(hydroxy-, ether and ester)-alkyl-2-amino-cycloalkyl and -omega-(hydroxy, ether and ester) alkyl-2-amino-cycloalkenyl and -cycloalkyl amide compounds. These compounds are noted for their potential as analgesic drugs with lower physical dependence liability compared to traditional opioids like morphine and methadone. His patents also include pharmaceutical compositions and methods for utilizing these compounds as analgesics.

Career Highlights

Kaplan has had a distinguished career, working with prominent companies such as The Upjohn Company and Allergan, Inc. His experience in these organizations has allowed him to contribute to the advancement of pharmaceutical science and innovation.

Collaborations

Throughout his career, Kaplan has collaborated with notable individuals, including Moses W McMillan and Jacob Szmuszkovicz. These partnerships have further enriched his work and expanded the scope of his inventions.

Conclusion

Lester J Kaplan's innovative contributions to the pharmaceutical industry demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com